Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug Posted on 15. June 2018 by Kristian Reichelt Post navigation Selective aptamer-based control of intraneuronal signalingImpaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human NaV1.1 mutation
